PeptideKey News
U.S. tariffs on Chinese pharmaceutical APIs hit 245%. BPC-157 costs up 38%. China supplies 40% of global peptide capacity. The supply chain math is breaking.
This article is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.